Congenital myasthenic syndromes are a rare group of heterogeneous diso
rders affecting neuromuscular transmission. Recent identification and
in-vitro functional analysis of some of the genetic mutations that cau
se these disorders correlates with previous electrophysiological, bioc
hemical, pathological and therapeutic studies, and has advanced our un
derstanding of neuromuscular transmission.